Loading stock data…
$0.75-0.12 (-13.53%)
China Pharma Holdings, Inc.
China Pharma Holdings, Inc. in the Healthcare sector is trading at $0.75 with a market capitalization of $33M. The stock is currently near its 52-week low of $0.38, remaining 13.6% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $948,340↓ | $983,536↓ | $1.23M↑ | $756,217↓ | $1.03M |
| Gross Profit | $83,566↓ | $285,487↑ | $150,775↑ | -$59,654↑ | -$87,010 |
| Operating Income | -$1.43M↓ | -$1.12M↑ | -$1.20M↓ | -$627,730↓ | -$501,430 |
| Net Income | -$1.46M↓ | -$1.14M↑ | -$1.22M↓ | -$651,482↓ | -$528,367 |
China Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products for human use in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and c...